China FDA overhaul could speed regulatory reforms

A major overhaul of China's ministries proposed by the State Council will create a State Drug Administration to oversee drug approvals and supervision. The change could focus regulators on implementing reforms aimed at raising China’s drug regulations to international standards because unlike China FDA, the new entity will not be responsible for food administration, according to Richard Yeh of Goldman Sachs.

The State Drug Administration will be part of a newly formed State Administration of Market Supervision, which will combine the responsibilities of CFDA and two other agencies...